Page last updated: 2024-08-24

gamma-bisabolene and Mouth Neoplasms

gamma-bisabolene has been researched along with Mouth Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CJ; Hua, CH; Huang, SH; Jou, YJ; Kao, JY; Lai, CH; Lin, CW; Liu, YC; Wang, CY; Way, TD	1

Other Studies

1 other study(ies) available for gamma-bisabolene and Mouth Neoplasms

Article	Year
Quantitative phosphoproteomic analysis reveals γ-bisabolene inducing p53-mediated apoptosis of human oral squamous cell carcinoma via HDAC2 inhibition and ERK1/2 activation. Proteomics, 2015, Volume: 15, Issue:19 Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Histone Deacetylase 2; Humans; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; Phosphoproteins; Proteomics; Sesquiterpenes; Tumor Suppressor Protein p53	2015

Article

Year

Quantitative phosphoproteomic analysis reveals γ-bisabolene inducing p53-mediated apoptosis of human oral squamous cell carcinoma via HDAC2 inhibition and ERK1/2 activation.

Proteomics, 2015, Volume: 15, Issue:19

Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Histone Deacetylase 2; Humans; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mouth Neoplasms; Phosphoproteins; Proteomics; Sesquiterpenes; Tumor Suppressor Protein p53

2015